83 related articles for article (PubMed ID: 2213190)
1. Investigation of physicochemical and in-vivo behavior of diastereomeric iron-59, gallium-68, and indium-111-EHPG trivalent metal complexes.
Madsen SL; Bannochie CJ; Martell AE; Mathias CJ; Welch MJ
J Nucl Med; 1990 Oct; 31(10):1662-8. PubMed ID: 2213190
[TBL] [Abstract][Full Text] [Related]
2. TMPHPG: a lipophilic derivative of EHPG for iron, gallium-68 and indium-111 hepatobiliary clearance.
Madsen SL; Bannochie CJ; Welch MJ; Mathias CJ; Martell AE
Int J Rad Appl Instrum B; 1991; 18(3):289-94. PubMed ID: 2071441
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of iron-chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron-chelating drug.
Hershko C; Grady RW; Link G
Br J Haematol; 1982 Jun; 51(2):251-60. PubMed ID: 7082583
[TBL] [Abstract][Full Text] [Related]
4. UV and fluorescence spectral changes induced by neodymium binding of N,N'-ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N' diacetic acid.
Wang Z; Yang B
Spectrochim Acta A Mol Biomol Spectrosc; 2006 Nov; 65(3-4):946-9. PubMed ID: 16684618
[TBL] [Abstract][Full Text] [Related]
5. Indium (III) and gallium (III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior.
Sun Y; Anderson CJ; Pajeau TS; Reichert DE; Hancock RD; Motekaitis RJ; Martell AE; Welch MJ
J Med Chem; 1996 Jan; 39(2):458-70. PubMed ID: 8558514
[TBL] [Abstract][Full Text] [Related]
6. Fe(III)-EHPG and Fe(III)-5-Br-EHPG as contrast agents in MRI: an animal study.
Liu GC; Wang YM; Jaw TS; Chen HM; Sheu RS
J Formos Med Assoc; 1993 Apr; 92(4):359-66. PubMed ID: 8104585
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
Hershko C; Grady RW; Link G
Haematologia (Budap); 1984; 17(1):25-33. PubMed ID: 6427069
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary MR contrast agents: 5-substituted iron-EHPG derivatives.
Lauffer RB; Vincent AC; Padmanabhan S; Villringer A; Saini S; Elmaleh DR; Brady TJ
Magn Reson Med; 1987 Jun; 4(6):582-90. PubMed ID: 3613958
[TBL] [Abstract][Full Text] [Related]
9. Chelating agents related to ethylenediamine bis(2-hydroxyphenyl)acetic acid (EDDHA): synthesis, characterization, and equilibrium studies of the free ligands and their Mg2+, Ca2+, Cu2+, and Fe3+ chelates.
Yunta F; García-Marco S; Lucena JJ; Gómez-Gallego M; Alcázar R; Sierra MA
Inorg Chem; 2003 Aug; 42(17):5412-21. PubMed ID: 12924915
[TBL] [Abstract][Full Text] [Related]
10. EHPG iron(III) complexes as potential contrast contrast agents for MRI.
Kuźnik N; Jewuła P; Oczek L; Kozłowicz S; Grucela A; Domagała W
Acta Chim Slov; 2014; 61(1):87-93. PubMed ID: 24664331
[TBL] [Abstract][Full Text] [Related]
11. Spectral studies on the interaction between lanthanum ion and the ligand: N,N'-ethylenebis-[2-(o-hydroxyphenolic)glycine].
Yaqin Z; Binsheng Y
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Nov; 62(1-3):641-4. PubMed ID: 16257770
[TBL] [Abstract][Full Text] [Related]
12. Iron-EHPG as an hepatobiliary MR contrast agent: initial imaging and biodistribution studies.
Lauffer RB; Greif WL; Stark DD; Vincent AC; Saini S; Wedeen VJ; Brady TJ
J Comput Assist Tomogr; 1985; 9(3):431-8. PubMed ID: 3989032
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Fe-HBED and Fe-EHPG as hepatobiliary MR contrast agents.
Hoener B; Engelstad BL; Ramos EC; Macapinlac HA; Price DC; Johnson TR; White DL
J Magn Reson Imaging; 1991; 1(3):357-62. PubMed ID: 1802149
[TBL] [Abstract][Full Text] [Related]
14. Reduction of paraquat-induced renal cytotoxicity by manganese and copper complexes of EGTA and EHPG.
Samai M; Hague T; Naughton DP; Gard PR; Chatterjee PK
Free Radic Biol Med; 2008 Feb; 44(4):711-21. PubMed ID: 18067869
[TBL] [Abstract][Full Text] [Related]
15. CE of phytosiderophores and related metal species in plants.
Xuan Y; Scheuermann EB; Meda AR; Jacob P; von Wirén N; Weber G
Electrophoresis; 2007 Oct; 28(19):3507-19. PubMed ID: 17768721
[TBL] [Abstract][Full Text] [Related]
16. Spectral studies on the interaction of yttrium ion with the ligands of phenolic groups: N,N'-Ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid.
Duan L; Zhao YQ; Yang BS
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Sep; 68(1):165-8. PubMed ID: 17267267
[TBL] [Abstract][Full Text] [Related]
17. Theoretical speciation of ethylenediamine-N-(o-hydroxyphenylacetic)-N'-(p-hydroxyphenylacetic) acid (o,p-EDDHA) in agronomic conditions.
Yunta F; García-Marco S; Lucena JJ
J Agric Food Chem; 2003 Aug; 51(18):5391-9. PubMed ID: 12926888
[TBL] [Abstract][Full Text] [Related]
18. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: synthesis, solution and in vivo evaluation.
Gama S; Gil M; Gano L; Farkas E; Amélia Santos M
J Inorg Biochem; 2009 Feb; 103(2):288-98. PubMed ID: 19091421
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of Fe-(5-C2H5-EHPG)- as a contrast agent in MR imaging of hepatobiliary system.
Sheu RS; Liu GC; Wang YM; Jaw TS; Chen HM; Kuo YT
Kaohsiung J Med Sci; 1997 Feb; 13(2):75-85. PubMed ID: 9099045
[TBL] [Abstract][Full Text] [Related]
20. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
